- Home
- SCLXW vs ONBPO Comparison
SCLXW vs ONBPO Comparison
Compare SCLXW & ONBPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- ONBPO
- Stock Information
- Founded
- SCLXW N/A
- ONBPO N/A
- Country
- SCLXW United States
- ONBPO United States
- Employees
- SCLXW 111
- ONBPO 5313
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- ONBPO Major Banks
- Sector
- SCLXW Health Care
- ONBPO Finance
- Exchange
- SCLXW Nasdaq
- ONBPO Nasdaq
- Market Cap
- SCLXW N/A
- ONBPO N/A
- IPO Year
- SCLXW N/A
- ONBPO N/A
- Fundamental
- Price
- SCLXW $0.45
- ONBPO $25.14
- Analyst Decision
- SCLXW
- ONBPO
- Analyst Count
- SCLXW 0
- ONBPO 0
- Target Price
- SCLXW N/A
- ONBPO N/A
- AVG Volume (30 Days)
- SCLXW 4.0K
- ONBPO N/A
- Earning Date
- SCLXW 03-07-2025
- ONBPO N/A
- Dividend Yield
- SCLXW N/A
- ONBPO N/A
- EPS Growth
- SCLXW N/A
- ONBPO N/A
- EPS
- SCLXW N/A
- ONBPO N/A
- Revenue
- SCLXW $55,152,000.00
- ONBPO N/A
- Revenue This Year
- SCLXW N/A
- ONBPO N/A
- Revenue Next Year
- SCLXW N/A
- ONBPO N/A
- P/E Ratio
- SCLXW N/A
- ONBPO N/A
- Revenue Growth
- SCLXW 22.02
- ONBPO N/A
- 52 Week Low
- SCLXW $0.18
- ONBPO N/A
- 52 Week High
- SCLXW $0.18
- ONBPO N/A
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- ONBPO 54.45
- Support Level
- SCLXW N/A
- ONBPO $25.05
- Resistance Level
- SCLXW N/A
- ONBPO $25.23
- Average True Range (ATR)
- SCLXW 0.00
- ONBPO 0.17
- MACD
- SCLXW 0.00
- ONBPO -0.00
- Stochastic Oscillator
- SCLXW 0.00
- ONBPO 62.03
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.